Literature DB >> 29404182

A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure.

Ashok Kuwal1, Vinod Joshi2, Naveen Dutt3, Surjit Singh4, Kailash Chand Agarwal5, Gopal Purohit6.   

Abstract

OBJECTIVES: Bacterial infections are the major cause of acute exacerbation of COPD (AE-COPD). The relationship between lung functions and respiratory failure (arterial blood gas parameters) with the etiology of AE-COPD has not been clearly understood. We conducted this study to determine the bacterial profile in AE-COPD and to identify the associated risk factors and drug sensitivity pattern.
MATERIAL AND METHODS: Seventy-two patients hospitalized for AE-COPD were prospectively evaluated. Quantitative sputum culture, blood gas analysis, and drug sensitivity testing were performed at the time of admission, and pulmonary function testing was performed 6 weeks after discharge as per standard guidelines.
RESULTS: Bacterial pathogens were isolated in 34 (47.22%) cases. Pathogens isolated were Pseudomonas aeruginosa (38.23%), Klebsiella pneumoniae (29.41%), Staphylococcus aureus (23.53%), Streptococcus pneumoniae (5.88%), and Acinetobacter spp. (2.94%). Isolation of bacterial pathogen was observed in patients with advancing age (p=0.02), frequent exacerbations (p<0.001), systemic steroid use (p=0.005), and deranged lung function (p=0.02). Binary logistic regression analysis revealed that higher partial pressure of carbon dioxide (PaCO2) was independently associated with isolation of K. pneumoniae (p=0.025) and P. aeruginosa (p=0.001). Additional independent factors that favor isolation of K. pneumoniae were age >55 years (p=0.017) and systemic steroid use (p=0.017). Antibiotic sensitivity testing showed that ciprofloxacin and piperacillin/tazobactum were effective in 27/34 (79.41%) of isolates followed by gentamycin in 26/34 (76%).
CONCLUSION: Hypercapnic respiratory failure is an independent risk factor for isolation of K. pneumoniae and P. aeruginosa in addition to advanced age and systemic steroid use. These findings may be an important adjunct in deciding the initial antibiotic therapy.

Entities:  

Keywords:  Chronic obstructive pulmonary disease; acute exacerbation; bacteria; lung function; respiratory failure

Year:  2017        PMID: 29404182      PMCID: PMC5783049          DOI: 10.5152/TurkThoracJ.2017.17035

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN: 2148-7197


  31 in total

Review 1.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

2.  A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD.

Authors:  Fanny W S Ko; Margaret Ip; Paul K S Chan; Joan P C Fok; Michael C H Chan; Jenny C Ngai; Doris P S Chan; David S C Hui
Journal:  Chest       Date:  2007-01       Impact factor: 9.410

Review 3.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

4.  Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD.

Authors:  M Miravitlles; C Espinosa; E Fernández-Laso; J A Martos; J A Maldonado; M Gallego
Journal:  Chest       Date:  1999-07       Impact factor: 9.410

Review 5.  Toward a consensus definition for COPD exacerbations.

Authors:  R Rodriguez-Roisin
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

Review 6.  Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Fernando J Martinez; MeiLan K Han; Kevin Flaherty; Jeffrey Curtis
Journal:  Expert Rev Anti Infect Ther       Date:  2006-02       Impact factor: 5.091

7.  Pseudomonas aeruginosa in chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Karen Eschberger; Phyllis Lobbins; Lori Grove; Xueya Cai; Sanjay Sethi
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

8.  Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush.

Authors:  E Monsó; J Ruiz; A Rosell; J Manterola; J Fiz; J Morera; V Ausina
Journal:  Am J Respir Crit Care Med       Date:  1995-10       Impact factor: 21.405

9.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.

Authors:  G C Donaldson; T A R Seemungal; A Bhowmik; J A Wedzicha
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

10.  Microbiological study of patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (AE-COPD) and the usefulness of analytical and clinical parameters in its identification (VIRAE study).

Authors:  Ramon Boixeda; Nuria Rabella; Goretti Sauca; Maria Delgado; Xavier Martínez-Costa; Montserrat Mauri; Vanessa Vicente; Elisabet Palomera; Mateu Serra-Prat; Josep Antón Capdevila
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-05-25
View more
  8 in total

1.  Changes in the expression level of IL-17A and p53-fibrinolytic system in smokers with or without COPD.

Authors:  Mahesh Manjunath Gouda; Sadiya Bi Shaikh; Deepu Chengappa; Irfan Kandhal; Ashwini Shetty; Yashodhar Bhandary
Journal:  Mol Biol Rep       Date:  2018-09-24       Impact factor: 2.316

2.  Head-to-head oral prophylactic antibiotic therapy for chronic obstructive pulmonary disease.

Authors:  Christopher Jd Threapleton; Sadia Janjua; Rebecca Fortescue; Emma H Baker
Journal:  Cochrane Database Syst Rev       Date:  2019-05-24

3.  Study of respiratory viruses and their coinfection with bacterial and fungal pathogens in acute exacerbation of chronic obstructive pulmonary diseases.

Authors:  Rahat Jahan; Baijayantimala Mishra; Bijayini Behera; Prasanta Raghab Mohapatra; Ashok Kumar Praharaj
Journal:  Lung India       Date:  2021 Jan-Feb

4.  Pathogens Isolated and Their Association With the Long-Term Outcome in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  C Mohan Rao; Kinshuk Sarbhai; Saswat Subhankar; Amrut Mohapatra; Nipa Singh; Prem S Panda; Shubhransu Patro; Sanghamitra Pati
Journal:  Cureus       Date:  2022-06-21

5.  Bacterial Isolates and Antibacterial Resistance Patterns in a Patient with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in a Tertiary Teaching Hospital, Southwest Ethiopia.

Authors:  Abdulhakim Mussema; Getenet Beyene; Mulatu Gashaw
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-08-31       Impact factor: 2.585

Review 6.  Appropriate antibiotic management of bacterial lower respiratory tract infections.

Authors:  Charles Feldman; Guy Richards
Journal:  F1000Res       Date:  2018-07-23

7.  The Value of Inflammatory Biomarkers in Differentiating Asthma-COPD Overlap from COPD.

Authors:  Meng Li; Tian Yang; Ruiqing He; Anqi Li; Wenhui Dang; Xinyu Liu; Mingwei Chen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-11-20

8.  Eosinopenia as a biomarker for antibiotic use in COPD exacerbations: protocol for a retrospective hospital-based cohort study.

Authors:  Mei Yang; Xuemei Liu; Qiongqiong Hu; Junjie Li; Sijia Fu; Daohong Chen; Yanqing Wu; Ai Luo; Xiawei Zhang; Ruizhi Feng; Guo Xu; Can Liu; Hongli Jiang; Wei Liu
Journal:  BMJ Open       Date:  2022-01-20       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.